4//SEC Filing
DArecca James 4
Accession 0001127602-22-014966
CIK 0000313143other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 4:34 PM ET
Size
7.1 KB
Accession
0001127602-22-014966
Insider Transaction Report
Form 4
DArecca James
EVP, Chief Financial Officer
Transactions
- Award
Common Stock
2022-05-16+4,774→ 10,676 total - Award
Non-qualified Stock Option (Right to Buy)
2022-05-16+11,163→ 11,163 totalExercise: $57.60Exp: 2029-05-16→ Common Stock (11,163 underlying)
Footnotes (4)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]This number includes unvested RSUs previously reported.
- [F4]Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001583903
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 4:34 PM ET
- Size
- 7.1 KB